UCLB is the commercialisation company of UCL. We bring to market truly world-leading, world-changing technologies, innovations that have a real and positive impact on people’s lives.
Apollo Therapeutics received recognition at the Praxis Auril KE Awards 2021, picking up Deal of the Year, for attracting major investment to empower a unique, multi-university portfolio-based biopharmaceuticals venture.
A gene therapy company formed from a UCLB spinout is developing potentially curative treatments for debilitating eye diseases including X-linked retinitis pigmentosa.
Find your business manager
Forms and resources
Find UCL innovations